9-valent HPV vaccine study for healthy Chinese women
Part of Cancer, Infections, Skin, Women’s health & pregnancy clinical trials.
This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a Chinese woman age 20 to 45 and have valid legal identification
- You can understand the study and sign informed consent, including follow-up visits
- Your recent sexual/activity and gynecology visit timing must match the rules (including no sex 48 hours before sample-collection visits, and no vaginal cleansing/medications 72 hours before)
- You must not have received any HPV vaccine before or during the study, including past trials
- Your pregnancy test must be negative at enrollment and you must use effective birth control during the required time window
- You must not have certain past HPV/major genital conditions, immune problems, or recent vaccines/illnesses that could affect safety
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new 15-valent HPV vaccine to see if it is safe and creates a strong immune response. If you are between 9 and 45 years old and have not had an HPV vaccine before, you may be able to join.
This trial studies whether a quadrivalent HPV vaccine is safe and helps the body build protection (immunity) against HPV. It enrolls healthy Chinese females who are not already treated for HPV-related infection.
This trial tests how well the HPV vaccine triggers immune memory in women who may have been exposed to HPV. It could help protect against future HPV infections and related cancers.
This study looks at giving the HPV vaccine (Gardasil 9) to women while they go through Sweden’s routine HPV screening. It helps researchers understand how vaccine use alongside screening affects HPV infection and cervical cancer prevention.
This study checks how well the HPV (cancer-preventing) vaccine protection stays in your body over time. It may help confirm the vaccine’s “long-lasting” immune response and guide future vaccination confidence.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.